Emergências e Terapia Intensiva
Estudo randomizado | Combinação de anticorpos REGEN-COV reduz hospitalizações em pacientes ambulatoriais com Covid-19.
1 Out, 2021 | 20:28hRevisão | Características clínicas, laboratoriais e achados radiológicos de pacientes com mielopatia inflamatória aguda após infecção por COVID-19.
1 Out, 2021 | 20:23hEstudo randomizado | Vasopressina + metilprednisolona aumenta a probabilidade de retorno da circulação espontânea em comparação ao placebo em pacientes com parada cardíaca em ambiente hospitalar.
1 Out, 2021 | 20:19hEffect of Vasopressin and Methylprednisolone vs Placebo on Return of Spontaneous Circulation in Patients With In-Hospital Cardiac Arrest: A Randomized Clinical Trial – JAMA (gratuito por tempo limitado)
Editorial: Vasopressin and Steroids as Adjunctive Treatment for In-Hospital Cardiac Arrest (gratuito por tempo limitado)
Comentário no Twitter
Randomized trial among patients with in-hospital cardiac arrest found that administration of vasopressin and methylprednisolone, compared with placebo, significantly increased the likelihood of return of spontaneous circulation https://t.co/wfyl56wgpT pic.twitter.com/LjKoxx8Rav
— JAMA (@JAMA_current) September 29, 2021
Casos de Medicina de Emergência | Emergências hepáticas – Insuficiência hepática aguda, encefalopatia hepática, síndrome hepatorrenal, interpretação de testes hepáticos e drogas a se evitar.
1 Out, 2021 | 20:05hSuplemento | Síndrome da angústia respiratória aguda.
1 Out, 2021 | 20:04hPágina principal: Acute Respiratory Distress Syndrome – Critical Care Clinics
The Epidemiology of Acute Respiratory Distress Syndrome Before and After Coronavirus Disease 2019
Toward Optimal Acute Respiratory Distress Syndrome Outcomes
Pathophysiology of Acute Respiratory Distress Syndrome and COVID-19 Lung Injury
COVID-19–Associated Acute Respiratory Distress Syndrome
Pathophysiology of the Acute Respiratory Distress Syndrome
Acute Kidney Injury and Acute Respiratory Distress Syndrome
Acute Respiratory Distress Syndrome
Fluid Therapy and Acute Respiratory Distress Syndrome
Pharmacologic Treatments for Acute Respiratory Distress Syndrome
Long-Term Outcomes in Acute Respiratory Distress Syndrome
Conteúdos relacionados:
Position paper: Advancing precision medicine for acute respiratory distress syndrome.
Review: Personalized mechanical ventilation in acute respiratory distress syndrome.
Seminar | Acute respiratory distress syndrome.
ARDS: Contemporary management and novel approaches during COVID-19
M-A | Eficácia e risco de infecções secundárias de tocilizumabe, sarilumabe e anakinra em pacientes com COVID-19.
1 Out, 2021 | 19:33hDiretriz de prática clínica da AGA sobre o tratamento de distúrbios de coagulação em pacientes com cirrose.
1 Out, 2021 | 19:20hVer também: AGA Technical Review on Coagulation in Cirrhosis – Gastroenterology
Revisão | Implementação de um algoritmo de exclusão precoce para o infarto agudo do miocárdio na prática clínica.
1 Out, 2021 | 19:11hImplementing an early rule-out pathway for acute myocardial infarction in clinical practice – Heart
Revisão | Condições cutâneas ameaçadoras à vida na terapia intensiva.
1 Out, 2021 | 18:25hLife-threatening skin conditions presenting to critical care – BJA Education
Podcast | Neutropenia febril.
1 Out, 2021 | 18:20h#288 LIVE! Neutropenic Fever featuring Dr. Susan Seo – The Curbsiders


